Overview

Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders

Status:
Recruiting
Trial end date:
2023-12-20
Target enrollment:
Participant gender:
Summary
This is a single-arm study to investigate 1-year treatment related mortality (TRM) in patients with life threatening non-malignant and malignant hematologic disorders who do not have a matched related donor for allogeneic transplantation.
Phase:
Phase 2
Details
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Treatments:
Busulfan
Clofarabine
Cyclosporine
Cyclosporins
Fludarabine
Mycophenolic Acid